Certified by Founder Lodge
Flashpoint Therapeutics
United States - Palo Alto, California
START UP
1 Disclosed Funding Rounds $10,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Flashpoint Therapeutics is developing a new class of cancer immunotherapies through rational nanoscale design of therapeutic architecture to optimize anti-tumor immune response.
Across 9 i
Beta Lab
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Latent | $80,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
games2gether | $5,202,945 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Avtal | $24,000,000 | (Mar 20, 2026)
